Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?
- 20 Downloads
The introduction of SCG for the treatment of bronchial asthma was viewed by many as the advent of a new era, the era of the antiallergic drug which acted by suppressing the release of inflammatory mediators from mast cells. However, some 17 years on, SCG is the only drug of its type on the market. Efforts to improve its efficacy by chemical modification have not succeeded. As it is now clear that all of the beneficial effects of SCG in asthma cannot be attributed to its effects on mast cell mediator secretion, it is not surprising that mast cell models are not predictive of clinical activity. Perhaps a clearer understanding of the basic bio-chemical mechanisms of SCG and its actions in animals and man may lead to development of more relevant models and to a more potent drug.
KeywordsAsthma Beneficial Effect Mast Cell Inflammatory Mediator Chemical Modification
Unable to display preview. Download preview PDF.
- J.S.G. Cox,Disodium cromoglycate (FPL 670, ‘Intal’): a specific inhibitor of reaginic antigen-antibody mechanisms, Nature (Lond.)81, 1328–1329 (1967).Google Scholar
- M.K. Church,Cromoglycate-like anti-allergic drugs: a review, Drugs of Today14, 281–341 (1978).Google Scholar
- T.S.C. Orr,Recent developments concerning the mast cell and the mode of action of disodium cromoglycate, Acta Allergol.12 (Suppl.), 13–29 (1975).Google Scholar
- J.C. Foreman, M.B. Hallett andJ.L. Mongar,Site of action of the anti-allergic drugs cromoglycate and doxantrazole. Br. J. Pharmacol.59, 473P-474P (1977).Google Scholar
- C. Sung, H.L. Saunders, R.D. Krell andL.W. Chakrin,Studies on the mechanism of tachyphylaxis to disodium cromoglycate, Int. Archs Allergy Appl. Immunol.55, 374–384 (1977).Google Scholar
- M.K. Church, Biochemical basis of pulmonary and anti-allergic drugs. InPulmonary and anti-allergic drugs, pp. 43–121 (Ed.J.P. Devlin). Wiley, New York 1985.Google Scholar
- W. Sieghart, T.C. Theoharides, S.L. Alper, W.W. Douglas andP. Greengard,Calcium dependent protein phosphorylation during secretion by exocytosis in the mast cell, Nature (Lond.)275, 329–331 (1978).Google Scholar
- K.D. Young andM.K. Church,Passive anaphylaxis in human lung fragments as a model for testing antiallergic drugs: its variability and constraints, Int. Archs Allergy Appl. Immunol.70, 138–142 (1983).Google Scholar
- M.K. Church, S.T. Holgate andG.J-K. Pao,Histamine release from mechanically and enzymatically dispersed human lung mast cells: inhibition by salbutamol and cromoglycate, Br. J. Pharmacol.79 (Suppl), 374P (1983).Google Scholar
- K.C. Flint, K.B.P. Leung, F.L. Pearce, B.N. Hudspith, J. Brostoff andN.McI. Johnson,Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate, Clin. Science68, 427–437 (1985).Google Scholar
- F.J. Breslin, E.R. McFadden andR.H. Ingram,The effects of cromolyn sodium on the airway response to hypnoea and cold air in asthma, Am. Rev. Respir. Dis.122, 11–16 (1980).Google Scholar
- M.J. Cushley, M.K. Church, G.J-K. Pao andS.T. Holgate,Adenosine induced bronchoconstriction is not caused by enhanced immunological release of mast cell mediators, Br. J. Clin. Pharmacol.14, 607P (1982).Google Scholar
- G.L. Larsen, M.P. Shampain, W.R. Marsh andB.L. Behrens, Animal model of the late asthmatic reaction to antigen challenge. InAsthma: physiology, immunopharmacology and treatment, pp. 245–258 (EdsA.B. Kay, K.F. Austen andL.M. Lichtenstein). Academic Press, London 1984.Google Scholar
- A.B. Kay, G.M. Walsh, G.M. Moqbel, A.J. MacDonald, T. Nagakura, M.P. Carrol andM.B. Richardson,Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. Submitted for publication.Google Scholar
- D.R. Buckle, Disodium cromoglycate and compounds with similar activities. InDevelopment of anti-asthma drugs, pp. 261–296 (EdsD.R. Buckle andH. Smith). Butterworths, London 1984.Google Scholar
- J.P. Devlin andK.D. Hargrave, Pulmonary and antiallergic drugs: Design and synthesis. InPulmonary and antiallergic drugs, pp. 191–316 (Ed.J.P. Devlin). Wiley, New York 1985.Google Scholar
- N. Eiser, H1-antihistamines. InDevelopment of antiasthmatic drugs, pp. 121–131 (EdsD.R. Buckle andH. Smith). Butterworths, London 1984.Google Scholar